Features associated with survival and disease-free survival in early endometrial cancer

Gregory P. Sutton, Hans E. Geisler, Frederick Stehman, Peter C M Young, Terry M. Kimes, Clarence E. Ehrlich

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Age, clinical stage, histologic grade, depth of myometrial penetration, adnexal status, peritoneal cytology, and progesterone and estrogen receptor status were available for 139 patients with clinical stage IA, IB, or II endometrial adenocarcioma who had therapy at Indiana University Hospital or St. Vincent Hospital in Indianapolis. These features were analyzed for their association with survival and disease-free survival. Patients treated at Indiana University Hospital were similar to those from St. Vincent Hospital when comparisons were made by χ2 test for age, clinical stage, grade, adnexal metastases, peritoneal cytologic results, progesterone receptor status, or estrogen receptor status. However, patients treated at Indiana University Hospital had lesions that were deeper (p = 0.03) than those treated at St. Vincent Hospital. Survival differences were observed for patients with progesterone receptor-rich versus progesterone receptor-poor tumors (p = 0.004), grades 1 and 2 versus grade 3 lesions (p = 0.013), and malignant versus benign peritoneal cytologic results (p = 0.01). Differences in disease-free survival were observed for those patients with adnexal metastases versus those with no adnexal disease (p = 0.002), those with estrogen receptor-rich versus estrogen receptor-poor tumors, outer third myometrial invasion (p = 0.002), and patients with clinical stage I versus clinical stage II disease (p = 0.03). A stepwise Cox proportional hazards model was constructed to determine correlates of disease-free survival. In the final model, grade (p = 0.0002), peritoneal cytologic results (p = 0.0002), progesterone receptor status (p = 0.004), and age as a continuous variable (p = 0.008) were most closely associated with disease-free survival.

Original languageEnglish
Pages (from-to)1385-1393
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume160
Issue number6
DOIs
StatePublished - 1989

Fingerprint

Endometrial Neoplasms
Disease-Free Survival
Progesterone Receptors
Estrogen Receptors
Survival
Adnexal Diseases
Neoplasm Metastasis
Proportional Hazards Models
Cell Biology
Neoplasms

Keywords

  • age
  • Endometrial cancer
  • peritoneal cytology
  • survival
  • tumor grade

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Features associated with survival and disease-free survival in early endometrial cancer. / Sutton, Gregory P.; Geisler, Hans E.; Stehman, Frederick; Young, Peter C M; Kimes, Terry M.; Ehrlich, Clarence E.

In: American Journal of Obstetrics and Gynecology, Vol. 160, No. 6, 1989, p. 1385-1393.

Research output: Contribution to journalArticle

Sutton, Gregory P. ; Geisler, Hans E. ; Stehman, Frederick ; Young, Peter C M ; Kimes, Terry M. ; Ehrlich, Clarence E. / Features associated with survival and disease-free survival in early endometrial cancer. In: American Journal of Obstetrics and Gynecology. 1989 ; Vol. 160, No. 6. pp. 1385-1393.
@article{7b54ac7a1b6c4663b91ac5bbb9c6e317,
title = "Features associated with survival and disease-free survival in early endometrial cancer",
abstract = "Age, clinical stage, histologic grade, depth of myometrial penetration, adnexal status, peritoneal cytology, and progesterone and estrogen receptor status were available for 139 patients with clinical stage IA, IB, or II endometrial adenocarcioma who had therapy at Indiana University Hospital or St. Vincent Hospital in Indianapolis. These features were analyzed for their association with survival and disease-free survival. Patients treated at Indiana University Hospital were similar to those from St. Vincent Hospital when comparisons were made by χ2 test for age, clinical stage, grade, adnexal metastases, peritoneal cytologic results, progesterone receptor status, or estrogen receptor status. However, patients treated at Indiana University Hospital had lesions that were deeper (p = 0.03) than those treated at St. Vincent Hospital. Survival differences were observed for patients with progesterone receptor-rich versus progesterone receptor-poor tumors (p = 0.004), grades 1 and 2 versus grade 3 lesions (p = 0.013), and malignant versus benign peritoneal cytologic results (p = 0.01). Differences in disease-free survival were observed for those patients with adnexal metastases versus those with no adnexal disease (p = 0.002), those with estrogen receptor-rich versus estrogen receptor-poor tumors, outer third myometrial invasion (p = 0.002), and patients with clinical stage I versus clinical stage II disease (p = 0.03). A stepwise Cox proportional hazards model was constructed to determine correlates of disease-free survival. In the final model, grade (p = 0.0002), peritoneal cytologic results (p = 0.0002), progesterone receptor status (p = 0.004), and age as a continuous variable (p = 0.008) were most closely associated with disease-free survival.",
keywords = "age, Endometrial cancer, peritoneal cytology, survival, tumor grade",
author = "Sutton, {Gregory P.} and Geisler, {Hans E.} and Frederick Stehman and Young, {Peter C M} and Kimes, {Terry M.} and Ehrlich, {Clarence E.}",
year = "1989",
doi = "10.1016/0002-9378(89)90859-4",
language = "English",
volume = "160",
pages = "1385--1393",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Features associated with survival and disease-free survival in early endometrial cancer

AU - Sutton, Gregory P.

AU - Geisler, Hans E.

AU - Stehman, Frederick

AU - Young, Peter C M

AU - Kimes, Terry M.

AU - Ehrlich, Clarence E.

PY - 1989

Y1 - 1989

N2 - Age, clinical stage, histologic grade, depth of myometrial penetration, adnexal status, peritoneal cytology, and progesterone and estrogen receptor status were available for 139 patients with clinical stage IA, IB, or II endometrial adenocarcioma who had therapy at Indiana University Hospital or St. Vincent Hospital in Indianapolis. These features were analyzed for their association with survival and disease-free survival. Patients treated at Indiana University Hospital were similar to those from St. Vincent Hospital when comparisons were made by χ2 test for age, clinical stage, grade, adnexal metastases, peritoneal cytologic results, progesterone receptor status, or estrogen receptor status. However, patients treated at Indiana University Hospital had lesions that were deeper (p = 0.03) than those treated at St. Vincent Hospital. Survival differences were observed for patients with progesterone receptor-rich versus progesterone receptor-poor tumors (p = 0.004), grades 1 and 2 versus grade 3 lesions (p = 0.013), and malignant versus benign peritoneal cytologic results (p = 0.01). Differences in disease-free survival were observed for those patients with adnexal metastases versus those with no adnexal disease (p = 0.002), those with estrogen receptor-rich versus estrogen receptor-poor tumors, outer third myometrial invasion (p = 0.002), and patients with clinical stage I versus clinical stage II disease (p = 0.03). A stepwise Cox proportional hazards model was constructed to determine correlates of disease-free survival. In the final model, grade (p = 0.0002), peritoneal cytologic results (p = 0.0002), progesterone receptor status (p = 0.004), and age as a continuous variable (p = 0.008) were most closely associated with disease-free survival.

AB - Age, clinical stage, histologic grade, depth of myometrial penetration, adnexal status, peritoneal cytology, and progesterone and estrogen receptor status were available for 139 patients with clinical stage IA, IB, or II endometrial adenocarcioma who had therapy at Indiana University Hospital or St. Vincent Hospital in Indianapolis. These features were analyzed for their association with survival and disease-free survival. Patients treated at Indiana University Hospital were similar to those from St. Vincent Hospital when comparisons were made by χ2 test for age, clinical stage, grade, adnexal metastases, peritoneal cytologic results, progesterone receptor status, or estrogen receptor status. However, patients treated at Indiana University Hospital had lesions that were deeper (p = 0.03) than those treated at St. Vincent Hospital. Survival differences were observed for patients with progesterone receptor-rich versus progesterone receptor-poor tumors (p = 0.004), grades 1 and 2 versus grade 3 lesions (p = 0.013), and malignant versus benign peritoneal cytologic results (p = 0.01). Differences in disease-free survival were observed for those patients with adnexal metastases versus those with no adnexal disease (p = 0.002), those with estrogen receptor-rich versus estrogen receptor-poor tumors, outer third myometrial invasion (p = 0.002), and patients with clinical stage I versus clinical stage II disease (p = 0.03). A stepwise Cox proportional hazards model was constructed to determine correlates of disease-free survival. In the final model, grade (p = 0.0002), peritoneal cytologic results (p = 0.0002), progesterone receptor status (p = 0.004), and age as a continuous variable (p = 0.008) were most closely associated with disease-free survival.

KW - age

KW - Endometrial cancer

KW - peritoneal cytology

KW - survival

KW - tumor grade

UR - http://www.scopus.com/inward/record.url?scp=0024384365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024384365&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(89)90859-4

DO - 10.1016/0002-9378(89)90859-4

M3 - Article

C2 - 2735364

AN - SCOPUS:0024384365

VL - 160

SP - 1385

EP - 1393

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -